Cargando…
CAR T cell therapy: newer approaches to counter resistance and cost
The genetically engineered Chimeric Antigen Receptor bearing T-cell (CAR T cell) therapy has been emerged as the new paradigm of cancer immunotherapy. However, recent studies have reported an increase in the number of relapsed haematological malignancies. This review provides newer insights into how...
Autores principales: | Yadav, Rajesh Kumar, Ali, Asgar, Kumar, Santosh, Sharma, Alpana, Baghchi, Basab, Singh, Pritanjali, Das, Sushmita, Singh, Chandramani, Sharma, Sadhana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171532/ https://www.ncbi.nlm.nih.gov/pubmed/32322738 http://dx.doi.org/10.1016/j.heliyon.2020.e03779 |
Ejemplares similares
-
Evaluation of C4b as an adjunct marker in symptomatic RT-PCR negative Covid-19 cases
por: Kumari, Bandana, et al.
Publicado: (2022) -
Molecular surveillance of insecticide resistance in Phlebotomus argentipes targeted by indoor residual spraying for visceral leishmaniasis elimination in India
por: Reid, Emma, et al.
Publicado: (2023) -
Mobile technology: A tool for healthcare and a boon in pandemic
por: Sharma, Sadhana, et al.
Publicado: (2022) -
Alzheimer's disease: Newer biomarkers
por: Dangi, Ankit, et al.
Publicado: (2021) -
Efficacy of Newer Molecules, Bioagents and Botanicals against Maydis Leaf Blight and Banded Leaf and Sheath Blight of Maize
por: Malik, Vinod Kumar, et al.
Publicado: (2018)